| Daniel M. Skovronsky |
Daniel M. Skovronsky founded Avid Radiopharmaceuticals, Inc. He is on the board of Myriad Genetics, Inc. and Indianapolis Museum of Art, Inc. and Executive VP, Chief Scientific & Medical Officer at Eli Lilly & Co. and Member of the University of Pennsylvania.
In the past Daniel M. Skovronsky occupied the position of Chief Executive Officer for Avid Radiopharmaceuticals, Inc.
He received a doctorate from the University of Pennsylvania, an undergraduate degree from Yale University and a doctorate from Perelman School of Medicine. |
| David A. Ricks |
David A. Ricks is a businessperson who has been the head of 7 different companies and currently holds the position of Chairman, President & Chief Executive Officer of Eli Lilly & Co. and Chairman & Chief Executive Officer of Eli Lilly & Co. Ltd. and Chairman & Chief Executive Officer at Eli Lilly Italia SpA (both are subsidiaries of Eli Lilly & Co.). He is also on the board of Adobe, Inc., Pharmaceutical Research & Manufacturers of America (former Chairman) and The Central Indiana Corporate Partnership and Member of The Business Roundtable, Member of The Business Council and Chairman-Governors Board at James Whitcomb Riley Children's Foundation.
David A. Ricks previously occupied the position of Principal at HP, Inc., Principal at International Business Machines Corp., President at Lilly USA LLC, President & General Manager at Lilly Industries Shanghai Ltd., General Manager of Eli Lilly Canada, Inc. and President at International Federation of Pharmaceutical Manufacturers.
He received an MBA from Indiana University and an undergraduate degree from Purdue University. |
| Donald A. Zakrowski |
Presently, Donald A. Zakrowski holds the position of Chief Accounting Officer & Vice President-Finance at Eli Lilly & Co.
He previously held the position of Senior Manager at PricewaterhouseCoopers LLP. |
| Anat Ashkenazi |
Anat Ashkenazi is on the board of Maravai Life Sciences, Inc. and Maravai Lifesciences Holdings, Inc. and Chief Financial Officer & Executive Vice President at Eli Lilly & Co.
She previously was Chief Financial Officer, Controller & Senior VP at Lilly Research Laboratories.
She received an undergraduate degree from The Hebrew University of Jerusalem and an MBA from Tel-Aviv University. |
| Diogo Rau |
Presently, Diogo Rau occupies the position of Senior VP, Chief Information & Digital Officer at Eli Lilly & Co.
He previously held the position of Senior Director-Information Systems & Technology at Apple, Inc. and Partner at McKinsey & Co., Inc.
Diogo Rau received an undergraduate degree and a graduate degree from Stanford University. |
| David Hyman |
David Hyman occupies the position of Chief Medical Officer at Eli Lilly & Co. and Chief Medical Officer at Loxo Oncology, Inc. (a subsidiary of Eli Lilly & Co.). |
| Patrik Jonsson |
Patrik Jonsson is Chief Customer Officer, EVP & President-Lilly USA at Eli Lilly & Co.
In the past he was President & General Manager at Eli Lilly Italia SpA.
Mr. Jonsson received an undergraduate degree from Lund University School of Economics & Management. |
| Alonzo Weems |
Currently, Alonzo Weems is President & Member at Indiana Board of Law Examiners. Dr. Weems is also on the board of International School of Indiana and Senior VP, Chief Ethics & Compliance Officer at Eli Lilly & Co.
Dr. Weems received an undergraduate degree from Wabash College and a doctorate from Indiana University Maurer School of Law. |
| Edgardo Hernandez |
Edgardo Hernandez is President-Manufacturing Operations & Senior VP at Eli Lilly & Co.
He received an undergraduate degree from the University of Puerto Rico and a graduate degree from North Carolina State University. |
| Jon Erik Fyrwald |
Jon Erik Fyrwald is an American businessperson who has been at the head of 16 different companies and currently holds the position of Chairman of ADAMA Ltd., Chairman & Chief Executive Officer for Syngenta Foundation For Sustainable Agriculture, Chief Executive Officer for Syngenta Crop Protection AG, Chief Executive Officer for Syngenta Crop Protection – Soluções Para A Agricultura, Ltda., Chief Executive Officer & Director at Syngenta Bangladesh Ltd., Chief Executive Officer & Director at Syngenta International AG, Chief Executive Officer & Director at Syngenta Group Co., Ltd. and Advisor at Beyondnetzero. Jon Erik Fyrwald is also on the board of 10 other companies.
Mr. Fyrwald previously was President for Ecolab, Inc. Chairman, President & Chief Executive Officer of Nalco Co. and Chairman, President & Chief Executive Officer for Nalco Holding Co. (both are subsidiaries of Ecolab, Inc.), Chairman at Sinofert Holdings Ltd., Chairman-Management & Member-Management Director at Syngenta AG, President & Chief Executive Officer for Univar NV, President & Chief Executive Officer of Univar Solutions UK Ltd., Chief Executive Officer for Univar Solutions USA, Inc. (Illinois), President, Chief Executive Officer & Director at Univar Solutions, Inc. and Group VP-Agriculture & Nutrition Division at EIDP, Inc.
Mr. Fyrwald received an undergraduate degree from the University of Delaware. |
| Juan Ricardo Luciano |
Currently, Juan Ricardo Luciano holds the position of Chairman, President & Chief Executive Officer at Archer-Daniels-Midland Co. He is also Member of The Business Roundtable, Member of US-China Business Council, Member of Dow Hydrocarbons & Resources LLC and Member of Global Advisory Board and on the board of 9 other companies.
In his past career Mr. Luciano held the position of President-Performance Division & Executive VP at The Dow Chemical Co.
Juan Ricardo Luciano received an undergraduate degree from Instituto Tecnológico de Buenos Aires. |
| Mary Lynne Hedley |
Mary Lynne Hedley founded Tesaro, Inc. and Zycos, Inc. Currently, Dr. Hedley is Venture Partner at Third Rock Ventures LLC. She is also on the board of 7 other companies.
In her past career Dr. Hedley was President & Chief Executive Officer for Zycos, Inc., President, Chief Operating Officer & Director at Tesaro, Inc., Chief Scientific Officer & Executive VP at MGI PHARMA, Inc., Chief Scientific Officer & EVP-Operations at Abraxis BioScience, Inc., Executive Vice President at Eisai Corp. of North America and General Manager & Senior Vice President at MGI PHARMA Biologics, Inc.
She received an undergraduate degree from Purdue University and a doctorate from The University of Texas Southwestern Medical Center. |
| Ralph Alvarez |
Ralph Alvarez is a businessperson who has been at the helm of 9 different companies. He is Chairman of First Watch Restaurant Group, Inc. Mr. Alvarez is also on the board of Eli Lilly & Co., Lowe's Cos., Inc. and Traeger, Inc. and Member-Presidents Council at the University of Miami School of Business.
In his past career he occupied the position of Chairman of Skylark Holdings Co., Ltd. and Executive Chairman at Skylark Co. Ltd. (a subsidiary of Skylark Holdings Co., Ltd.), President, Chief Operating Officer & Director at McDonald's Corp. President at McDonald's USA LLC, President for McDonald’s North America and President for McDonald's Mexico (which are all subsidiaries of McDonald's Corp.), Partner at Advent International Corp., Regional Director at Chipotle Mexican Grill, Inc., Budget Analyst at Burger King Corp., President at Burger King Restaurant of Canada, Inc., Vice President at Wendy's International LLC, Managing Director at Burger King España SL and President for Ronald McDonald House Charities Central West.
Ralph Alvarez received an undergraduate degree from the University of Miami. |
| Gabrielle G. Greene-Sulzberger |
Gabrielle joined Centerbridge in 2021 as a Senior Advisor and focuses on investments in the consumer, financial services and real estate sectors. She is a seasoned financial executive with over 30 years of experience assisting public and privately held companies in consumer products, retail, financial services and life sciences. Gabrielle has helped companies globally navigate disruption and transformation, execution of major M&A transactions, and engagement with shareholder activists. She brings deep corporate governance experience through her work with corporate boards and is qualified to serve on Audit Committees as a financial expert.
Until August of 2017, Ms. Sulzberger served as Chairman of the board of Whole Foods, where for 13 years she had previously served as Chair of the company’s Audit Committee. Gabrielle currently serves on the board of Acorns Advisers, LLC, where she chairs the Audit Committee, Cerevel Therapeutics, Eli Lilly, MasterCard, as a member of the Governance Committee, and Warby Parker, where she chairs the Governance Committee. She also serves on several private company boards: True Food Kitchen, where she is Chairman of the Board, and AuxMoney. Previously, Ms. Sulzberger served on five other public company boards: Brixmor Property Group, where she chairs the Governance Committee and is a member of the Audit Committee, Teva Pharmaceuticals, Stage Stores, IndyMac Bank, and Bright Horizons, and numerous private company boards.
EDUCATION
The Woodrow Wilson School of Princeton University, B.A.
Harvard Business School, M.B.A.
Harvard Law School, J.D. |
| William G. Kaelin |
William G. Kaelin is an entrepreneur who founded Tango Therapeutics, Inc., Tango Therapeutics Sub, Inc. and Cedilla Therapeutics, Inc. Currently, he occupies the position of Advisor at Casdin Capital. Dr. Kaelin is also Professor at Dana-Farber Cancer Institute, Inc., Professor at The Brigham & Women's Hospital, Inc., Member of National Academy of Sciences, Member of American Academy of Arts & Sciences, Member of Association of American Physicians, Member of Dana-Farber, Member of American Society of Clinical Investigation and Professor at Harvard Medical School and on the board of 5 other companies.
Dr. Kaelin previously was Chief Resident & House Officer at The Johns Hopkins Hospital, Inc., Member of American College of Physicians, Inc., Member-Advisory Board at National Cancer Institute and Member of National Academy of Medicine (United States).
He received an undergraduate degree from Duke University. |
| Jamere Jackson |
Presently, Jamere Jackson holds the position of Chief Financial Officer for AutoZone, Inc. Mr. Jackson is also on the board of Eli Lilly & Co. and Azaa Investments, Inc.
In his past career he was Chief Financial Officer at The Nielsen Company (US) LLC, Principal at General Electric Co. and Treasurer at Unison Industries LLC (a subsidiary of General Electric Co.), Principal at Procter & Gamble Co., Principal at Yum! Brands, Inc., Chief Financial Officer & Executive Vice President at The Hertz Corp., Chief Financial Officer of Nielsen NV, Chief Financial Officer at Nielsen Holdings Ltd., Chief Financial Officer of The Nielsen Co. BV, Senior Executive-Finance at GE Aviation Systems LLC, Chief Financial Officer & Executive Vice President of Hertz Global Holdings, Inc., Principal at First Data Corp., Principal at Total System Services and VP, Chief Financial Office-Drilling & Surface at Baker Hughes Energy Services LLC.
He received an undergraduate degree from the University of Notre Dame. |
| Katherine Baicker |
Katherine Baicker is on the board of Eli Lilly & Co., Mayo Clinic, The Chicago Council on Global Affairs and National Opinion Research Center and Member of Council on Foreign Relations, Inc., Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Research Associate at National Bureau of Economic Research, Inc., Member of National Academy of Social Insurance, Dean & Professor at The University of Chicago Harris School of Public Policy and Dean at Harris School of Public Policy Studies.
Dr. Baicker previously held the position of Member-Editorial Board at Health Affairs, Chairman for The Group Insurance Commission, Chairman-Social Sciences & Population Study at National Institutes of Health, Member of Council of Economic Advisers, Associate Professor & Assistant Professor at Dartmouth College and Professor-Health Economics at Harvard T.H. Chan School of Public Health.
Katherine Baicker received an undergraduate degree from Yale University and a doctorate from Harvard University. |
| Marschall S. Runge |
Marschall S. Runge is on the board of Eli Lilly & Co. and Michigan Medicine and Executive Vice President-Medical Affairs & Dean at the University of Michigan, Member of National Institutes of Health and Director-North Carolina Translational at The University of North Carolina at Charlotte.
Marschall S. Runge previously occupied the position of Faculty Member at The General Hospital Corp., Associate Professor at Emory University, Director-Cardiology & Sealy Center at the University of Texas Medical Branch, Director-Cardiology Division at Galveston College and Executive Dean & Chairman-Medicine Department at UNC School of Medicine.
Dr. Runge received a doctorate from Vanderbilt University and an undergraduate degree from The Johns Hopkins University School of Medicine. |
| Karen Walker |
Karen Walker holds the position of Chief Marketing Officer & Senior Vice President for Intel Corp. Ms. Walker is also on the board of Eli Lilly & Co., Association of National Advertisers, Sprout Social, Inc. and The Munn Group, Inc. and Member of Marketers That Matter.
In the past Karen Walker held the position of Chief Marketing Officer & Senior Vice President of Cisco Systems, Inc. and Vice President-Strategy & Marketing at HP, Inc.
She received an undergraduate degree from Loughborough University. |
| Kimberly H. Johnson |
Currently, Kimberly H. Johnson holds the position of Chief Operating Officer of T. Rowe Price Group, Inc. She is also on the board of 8 other companies.
She previously was Chief Operating Officer & Executive Vice President for Federal National Mortgage Association and Equity Trader at D.E. Shaw & Co. LLC.
She received an MBA from Columbia Business School and an undergraduate degree from Princeton University. |
